Item
Vanadium Aspartate 0.1% K (WS-81038)
100% Vanadium Aspartate
Mineral / Salt
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| WRIGHT PHARMA, INC. | 700 Kiernan Ave. Ste. A Modesto, CA 95356 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens EU/UK | WRIGHT PHARMA, INC. | Allergens EU/UK.pdf | 4/21/2022 | 4/20/2024 |
| Allergens | WRIGHT PHARMA, INC. | Allergens.pdf | 4/21/2022 | 4/20/2024 |
| Country of Origin EU/UK | WRIGHT PHARMA, INC. | Country of Origin EU/UK.pdf | 4/21/2022 | 4/20/2025 |
| Country of Origin | WRIGHT PHARMA, INC. | Country of Origin.pdf | 4/21/2022 | 4/20/2025 |
| National Bioengineered Food Disclosure Standard (Simplified) | WRIGHT PHARMA, INC. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 4/21/2022 | 4/20/2025 |
| Nutrition EU/UK | WRIGHT PHARMA, INC. | Nutrition EU/UK.pdf | 4/21/2022 | 4/20/2025 |
| Nutrition | WRIGHT PHARMA, INC. | Nutrition.pdf | 4/21/2022 | 4/20/2025 |
| BSE - TSE | WRIGHT PHARMA, INC. | WS-81038 BSE Statement.pdf | 4/22/2022 | 4/21/2025 |
| CoA Sample | WRIGHT PHARMA, INC. | WS-81038 COA.pdf | 5/26/2022 | 5/25/2024 |
| Gluten | WRIGHT PHARMA, INC. | WS-81038 Gluten Statement.pdf | 4/22/2022 | 4/22/2023 |
| GRAS/NDI/ODI Statement | WRIGHT PHARMA, INC. | WS-81038 GRAS Statement.pdf | 10/27/2022 | 10/31/2023 |
| Halal | WRIGHT PHARMA, INC. | WS-81038 Halal Compliance.pdf | 4/22/2022 | 4/30/2023 |
| Ingredient Statement | WRIGHT PHARMA, INC. | WS-81038 Ingredients Composition Range.pdf | 4/21/2022 | 4/21/2023 |
| Kosher | WRIGHT PHARMA, INC. | WS-81038 Kosher.pdf | 4/26/2022 | 4/30/2023 |
| GMO | WRIGHT PHARMA, INC. | WS-81038 Non-GMO Statement.pdf | 4/22/2022 | 4/21/2024 |
| Organic | WRIGHT PHARMA, INC. | WS-81038 Organic Declaration.pdf | 4/22/2022 | 4/30/2023 |
| Irradiation Status Statement | WRIGHT PHARMA, INC. | WS-81038 Organic Declaration.pdf | 4/22/2022 | 4/21/2024 |
| Sewage Statement | WRIGHT PHARMA, INC. | WS-81038 Organic Declaration.pdf | 4/22/2022 | 4/21/2024 |
| EtO Statement | WRIGHT PHARMA, INC. | WS-81038 Organic Declaration.pdf | 4/22/2022 | 4/21/2024 |
| California Prop. 65 | WRIGHT PHARMA, INC. | WS-81038 Prop 65 Statement.pdf | 4/22/2022 | 4/21/2024 |
| Pesticide | WRIGHT PHARMA, INC. | WS-81038 Residual Pesticide Statement.pdf | 4/22/2022 | 4/21/2024 |
| Residual Statement | WRIGHT PHARMA, INC. | WS-81038 Residual Solvent Statement.pdf | 4/22/2022 | 4/22/2023 |
| Safety Data Sheet (SDS) | WRIGHT PHARMA, INC. | WS-81038 Vanadium Aspartate 01 SDS.pdf | 4/21/2022 | 4/20/2025 |
| Product Specification Sheet | WRIGHT PHARMA, INC. | WS-81038 Vanadium Aspartate 01.pdf | 4/21/2022 | 4/20/2025 |
| Vegan/Vegetarian Statement | WRIGHT PHARMA, INC. | WS-81038 Vegan Statement.pdf | 4/22/2022 | 4/21/2024 |
| WADA/NSF/NFL Statement | WRIGHT PHARMA, INC. | WS-81038 WADA Statement.pdf | 4/22/2022 | 4/21/2024 |
